Abstract:Abstract Background and Aims Microcirculatory dysfunction is common in ESKD-patients and may play a pivotal role in their cardiovascular burden. Besides traditional and chronic-kidney-disease (CKD)-specific risk factors, dialysis itself might contribute to the dysfunction of the microcirculation (MC). Although an intradialytic fall in systemic blood pressure (BP) may directly influence the microcirculatory perfusion, vascular beds in different organs may not react uniformly. This systematic review and meta-analysis evaluated the acute impact of hemodialysis (HD) and hemodiafiltration (HDF) on the MC in various vascular beds. Methods Pubmed and Embase databases were systematically explored until June 2023 by two independent researchers. All observational and interventional studies in ESKD patients that reported dialysis-induced alterations of the MC, measured at the cutaneous, sublingual, retinal, muscle or coronary beds were eligible. Dialysis-induced changes were extracted and pooled, using a fixed-effects meta-analysis when the studies were reasonably homogeneous in terms of outcomes and methodology. Results 17 Studies with 493 participants were included. Virtually all patients (99.8%) were treated with HD. No eligible studies on coronary or muscle MC were identified. Cutaneous MC was investigated in 7 studies, showing a mean reduction in transcutaneous oxygen pressure of −7.9 mmHg (95% CI −10.5 to –5.3, n = 4 studies) and a mean reduction in blood flow of −0.9 arbitrary units (95% CI −1.2 to −0.6, n = 3 studies). Cutaneous vasoreactivity was diminished in 2 out of 3 studies (reactive maximum microvascular hyperemia: −36% (p < 0.05); time to reach baseline skin temperature after standardized cooling: 65.6 seconds (p-value not reported); vs. no significant change in post-ischemic maximal flow (2.5, p = not significant (N.S.)). Sublingual MC was assessed in 3 studies, showing a mean decrease in microvascular flow index of −0.6 in small microvessels (vessel diameter (VD) <20-25 μm, 95% CI −1.0 to −0.2, n = 3 studies), but no significant change in proportion of perfused vessels (−0.5%, 95% CI −1.2 to 0.2, n = 2 studies). One study showed a significant reduction in sublingual perfused vessel density after treatment (VD <20 μm: −1.6 ± 3.1, p < 0.05; VD >20 μm: −0.6 ± 1.1, p < 0.05), whereas total vessel density was unaffected in another study (VD <20 μm: 0.5, p = N.S.). Retinal MC was investigated in 7 studies, showing that the perfused vessel density (PVD) remained unchanged in both the superficial and deep capillary plexus (PVD SCP −0.48, 95% CI (−0.99; 0.03); PVD DCP −0.48, 95% CI (−1.18; 0.23), n = 4 studies). One study reported a decreased PVD at the outer retina (−1.3 ± 5.7, p < 0.05), while conflicting results were observed in 2 studies (0.1, p = N.S.; vs. −2.9 ± 4.3, p < 0.001), reporting the PVD at the choriocapillaris level. One study found no change in retinal blood flow (0.4, p = N.S.). With regard to vessel diameter changes, an increase in retinal venular diameter was observed in 3 studies (retinal venular diameter: 11.2 μm, p = 0.002; central retinal vein equivalent: 12.7 μm, p < 0.001; retinal vessel diameter: 4.4, p < 0.01), and one study described impaired venular dilatation in response to flicker light (−4.0, p = 0.04). Conclusions Hemodialysis induces microvascular dysfunction in different organs, but its impact varies between vascular beds. Microvascular perfusion was most significantly impaired in the cutaneous and sublingual regions, whereas the retinal microcirculatory perfusion remained unaltered. Literature on the effect of hemodiafiltration on the MC is lacking.

ACUTE VASCULAR RESPONSE TO HEMODIALYSIS AS MEASURED BY SERUM SYNDECAN-1 AND ENDOTHELIN-1 LEVELS, AS WELL AS VASCULAR STIFFNESS

Association between Visit-to-Visit Ultrafiltration Volume Variability, Vascular Biomarkers and Cardiovascular Parameters in Chronic Hemodialysis Patients

Pro- and anti-inflammatory factors, vascular stiffness and outcomes in chronic hemodialysis patients

The arterial stiffness changes in hemodialysis patients with chronic kidney disease: The impact on mortality

Endothelin-1, Extracellular Volume Overload, and Hemodynamics in Hemodialysis Patients

Measures of wave intensity as a non-invasive surrogate for cardiac function predicts mortality in haemodialysis patients

Impact of Hemodialysis on Left Ventricular-Arterial Coupling in End-Stage Renal Disease Patients

Dynamics of Cardiac Autonomic Responses During Hemodialysis Measured by Heart Rate Variability and Skin Sympathetic Nerve Activity: The Impact of Interdialytic Weight Gain

Echocardiographic Indices in Patients with End-Stage Renal Disease and Their Association with Hemodialysis-to-Hemodiafiltration Transfer: A Prospective Observational Study

Heart rate variability at rest and in response to stress: Comparative study between hemodialysis and peritoneal dialysis patients

Coronary Artery Disease in Patients Undergoing Hemodialysis: A Problem that Sounds the Alarm

EFFECT OF HEMODIALYSIS WITH MEDIUM CUT-OFF vs. HIGH-FLUX MEMBRANES ON ENDOTHELIAL FUNCTION OF PATIENTS WITH CHRONIC KIDNEY DISEASE

Evaluation of skin microcirculation during hemodialysis

Effect of renal dialysis session on novel echocardiographic parameters of left and right ventricle in patients with end-stage renal disease

Pilot study to investigate differences in middle molecules, oxidative stress and markers of peripheral vascular disease in patients treated by high flux haemodialysis and haemodiafiltration

#2851 Effects of dialysis on various microcirculatory beds in end-stage kidney disease (ESKD): a systematic review and meta-analysis

Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study

Acute Effects of Hemodiafiltration Versus Conventional Hemodialysis on Endothelial Function and Inflammation: A Randomized Crossover Study.

Intravital microscopic observation of the microvasculature during hemodialysis in healthy rats

Inflammation enhances cardiovascular risk and mortality in hemodialysis patients

High-efficiency on-line haemodiafiltration improves conduit artery endothelial function compared with high-flux haemodialysis in end-stage renal disease patients